Post-training CB1 cannabinoid receptor agonist activation disrupts long-term consolidation of spatial memories in the hippocampus

Neuroscience

Volumn 151, Issue 4, 2008, Pages 929-936

  Yim, T T ^a   Hong, N S ^a   Ejaredar, M ^a   McKenna, J E ^b   McDonald, R J ^a  

^a UNIVERSITY OF LETHBRIDGE   (Canada)

^b ST FRANCIS XAVIER UNIVERSITY   (Canada)

Author keywords

cannabinoids; CB1 receptor; consolidation; hippocampus; spatial memory; WIN 55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR AGONIST; DIMETHYL SULFOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; LONG TERM MEMORY; MALE; MAZE TEST; MEMORY CONSOLIDATION; MEMORY DISORDER; NONHUMAN; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; TASK PERFORMANCE;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BENZOXAZINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY DISORDERS; MORPHOLINES; NAPHTHALENES; RATS; RATS, LONG-EVANS; REACTION TIME; RECEPTOR, CANNABINOID, CB1; SPACE PERCEPTION; TIME FACTORS;

EID: 39149124436     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.08.037     Document Type: Article

References (42)

1. Baker D., Pryce G., Davies W.L., and Hiley C.R. In silico patent searching reveals a new cannabinoid receptor. Trends Pharmacol Sci 27 (2006) 1-4
2. Castellano C., Rossi-Arnaud C., Cestari V., and Costanzi M. Cannabinoids and memory: animal studies. Curr Drug Targets CNS Neurol Disord 2 6 (2003) 389-402
3. Cimadevilla J.M., Miranda R., Lopez L., and Arias J.L. Partial unilateral inactivation of the dorsal hippocampus impairs spatial memory in the MWM. Brain Res Cogn Brain Res 25 3 (2005) 741-746
4. Darmani N.A., Sim-Selley L.J., Martin B.R., Janoyan J.J., Crim J.L., Parekh B., and Breivogel C.S. Antiemetic and motor-depressive actions of CP55,940: Cannabinoid CB1 receptor characterization, distribution, and G-protein activation. Eur J Pharm 459 (2002) 83-95
5. Davies S.N., Pertwee R.G., and Riedel G. Functions of cannabinoid receptors in the hippocampus. Neuropharmacology 42 (2002) 993-1007
6. Drews E., Schneider M., and Koch M. Effects of the cannabinoid receptor agonist WIN 55,212-2 on operant behaviour and locomotor activity in rats. Pharmacol Biochem Behav 80 (2005) 145-150
7. Egashira N., Mishima K., Iwasaki K., and Fujiwara M. Intracerebral microinjections of delta 9-tetrahydrocannabinol: search for the impairment of spatial memory in the eight-arm radial maze in rats. Brain Res 952 2 (2002) 239-245
8. Fan S.F., and Yazulla S. Biphasic modulation of voltage-dependent currents of retinal cones by cannabinoid CB1 receptor agonist WIN 55,212-2. Vis Neurosci 20 (2003) 177-188
9. Ferbinteanu J., and McDonald R.J. Dorsal and ventral hippocampus: same or different?. Psychobiology 28 3 (2000) 314-324
10. Ferbinteanu J., and McDonald R.J. Both dorsal and ventral hippocampus contribute to spatial learning in Long-Evans rats. Neurosci Lett 345 2 (2003) 131-135
11. Gais S., and Born J. Low acetylcholine during slow-wave sleep is critical for declarative memory consolidation. Learn Mem 11 6 (2004) 679-685
12. Gaoni Y., and Mechoulam R. Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 86 (1964) 1646-1647
13. Giovannini M.G., Mutolo D., Bianchi L., Michelassi A., and Pepeu G. NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: A microdialysis study. J Neurosci 14 (1994) 1358-1365
14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 42 4 (2003) 327-360
15. Grotenhermen F. Cannabinoids. Curr Drug Targets CNS Neurol Disord 4 5 (2005) 507-530
16. Hannesson D.K., Wallace A.E., Pollock M., Corley S., Mohapel P., and Corcoran M.E. The relation between extent of dorsal hippocampal kindling and delayed-match-to-place performance in the Morris water maze. Epilepsy Res 58 2-3 (2004) 145-154
17. Holahan M.R., Taverna F.A., Emrich S.M., Louis M., Muller R.U., Roder J.C., and McDonald R.J. Impairment in long-term retention but not short-term performance on a water maze reversal task following hippocampal or mediodorsal striatal N-methyl-D-aspartate receptor blockade. Behav Neurosci 119 6 (2005) 1563-1571
18. Lichtman A.H., Dimen K.R., and Martin B.R. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology (Berl) 119 3 (1995) 282-290
19. Mailleux P., Parmentier M., and Vanderhaeghen J.J. Distribution of cannabinoid receptor messenger RNA in the human brain: an in situ hybridization histochemistry with oligonucleotides. Neurosci Lett 143 1-2 (1992) 200-204
20. Mailleux P., and Vanderhaeghen J.J. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48 3 (1992) 655-668
21. Mallet P.E., and Beninger R.J. The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. Psychopharmacology (Berl) 140 1 (1998) 11-19
22. Martin W.J., Coffin P.O., Attias E., Balinsky M., Tsou K., and Walker J.M. Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections. Brain Res 822 (1999) 237-242
23. McDonald R.J., and Hong N.S. Rats with hippocampal damage are impaired on place learning in the water task when overtrained under constrained conditions. Hippocampus 10 2 (2000) 153-161
24. McDonald R.J., Hong N.S., Craig L.A., Holahan M.R., Louis M., and Muller R.U. NMDA-receptor blockade by CPP impairs post-training consolidation of a rapidly acquired spatial representation in rat hippocampus. Eur J Neurosci 22 5 (2005) 1201-1213
25. Melis M., Pistis M., Perra S., Muntoni A.L., Pillolla G., and Gessa G.L. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci 24 1 (2004) 53-62
26. Misner D.L., and Sullivan J.M. Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J Neurosci 19 16 (1999) 6795-6805
27. Morris R.G., Garrud P., Rawlins J.N., and O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 297 5868 (1982) 681-683
28. Moser E.I., Moser M.B., and Andersen P. Spatial learning impairment parallels the magnitude of dorsal hippocampus lesions, but is hardly present following ventral lesions. J Neurosci 13 (1993) 3916-3925
29. Nava F., Carta G., Colombo G., and Gessa G.L. Effects of chronic delta (9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze. Neuropharmacology 41 3 (2001) 392-399
30. Pamplona F.A., and Takahashi R.N. WIN 55,212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors. Neurosci Lett 397 1-2 (2006) 88-92
31. Papafotiou K., Carter J.D., and Stough C. The relationship between performance on the standardised field sobriety tests, driving performance and the level of delta 9-tetrahydrocannabinol (THC) in blood. Forensic Sci Int 155 2-3 (2005) 172-178
32. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 4th ed. (1998), Academic Press, Toronto
33. Pistis M., Perra S., Pillolla G., Melis M., Gessa G.L., and Muntoni A.L. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: Evidence for CB1- and non-CB1-mediated actions. Neuropharmacology 46 (2004) 115-125
34. Sanudo-Pena M.C., Romero J., Seale G.E., Fernandez-Ruiz J.J., and Walker J.M. Activational role of cannabinoids on movement. Eur J Pharm 391 (2000) 269-274
35. Shimizu E., Tang Y.P., Rampon C., and Tsien J.Z. NMDA receptor- dependent synaptic reinforcement as a crucial process for memory consolidation. Science 290 5494 (2000) 1170-1174
36. Sulcova E., Mechoulam R., and Fride E. Biphasic effects of anandamide. Pharmacol Biochem Behav 59 (1997) 347-352
37. Sutherland R.J., Kolb B., and Whishaw I.Q. Spatial mapping: definitive disruption by hippocampal or medial frontal cortical damage in the rat. Neurosci Lett 31 3 (1982) 271-276
38. Takahashi R.N., Pamplona F.A., and Fernandes M.S. The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze. Neurosci Lett 380 3 (2005) 270-275
39. Terranova P., Michaud J.C., Le Fur G., and Soubrie P. Inhibition of long-term potentiation in rat hippocampal slices by anadamide and WIN 55,212-2: reversal by SR141716A, a selective antagonist of CB1 cannabinoid receptors. Naunyn Schmiedebergs Arch Pharmacol 352 (1995) 576-579
40. Tzavara E.T., Wade M., and Nomikos G.G. Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: site and mechanism of action. J Neurosci 23 28 (2003) 9374-9384
41. Varvel S.A., and Lichtman A.H. Evaluation of CB1 receptor knockout mice in the Morris water maze. J Pharmacol Exp Ther 301 3 (2002) 915-924
42. Wadsworth E.J., Moss S.C., Simpson S.A., and Smith A.P. Cannabis use, cognitive performance and mood in a sample of workers. J Psychopharmacol 20 1 (2006) 14-23